FDA Launches Initiative to Reduce Radiation Exposure from Medical Exams

In response to growing concerns about the side effects of radiation exposure during medical procedures, the FDA has launched a new initiative designed to reduce unnecessary exposure from CT scans, nuclear medicine studies and fluoroscopy.

The initiative, announced this month by the FDA, seeks to reduce the risk of radiation exposure from medical procedures through promotion of the safe use of medical devices, by providing support for informed clinical decision-making, and by making patients more aware of their total radiation exposure. The FDA is also considering increased requirements for computed tomography (CT) scanners and fluoroscopic devices that would call for increased safeguards and training to protect against radiation overexposure.

The agency will hold public hearings on March 30 and 31 to discuss possible new industry-wide requirements.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

“The amount of radiation Americans are exposed to from medical imaging has dramatically increased over the past 20 years,” said the FDA’s director of it’s Center for Devices and Radiological Health, Dr. Jeffrey Shuren. “The goal of FDA’s initiative is to support the benefits associated with medical imaging while minimizing the risks.”

The guidance comes as the FDA is investigating cases of radiation problems with CT scan procedures, after the discovery that a number of patients across the country have suffered radiation overexposure from scans performed incorrectly. The FDA released interim guidance in December for health care professionals and radiologists as it continues its investigation. The guidance advised them to review procedures and CT scan settings, and to be thorough in checking the amount of dosage prescribed for each CT scan patient.

In many cases, patients received radiation doses to the wrong parts of the body, or were subjected to radiation several times higher than prescribed. Diversified Clinical Services, the country’s largest wound care company, treated 3,000 radiation injuries in 2009 alone.

A CT scan radiation exposure study published in December in the Archives of Internal Medicine, which studied 1,119 adults who received CT scans in San Francisco in 2008, found a high amount of variation between radiation doses, with some radiation exposure varying as much as 13-fold between scans. The study estimated that 1 in 270 women who received a CT heart scan would develop cancer, compared to 1 in 600 men.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted today)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 4 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.